Publication & Citation Trends
Publications
0 total
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial. OA
Cited by 83
Semantic Scholar
The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses OA
Cited by 84
Semantic Scholar
The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee – Poster Session (P183-P186) OA
Cited by 0
Semantic Scholar
MO007A PHASE 1B MULTIPLE ASCENDING-DOSE STUDY OF A CD6 TARGETED THERAPY, ITOLIZUMAB, IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT ACTIVE PROLIFERATIVE LUPUS NEPHRITIS OA
Cited by 0
Semantic Scholar
Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease OA
Cited by 2
Semantic Scholar
38 History of pulmonary exacerbations (PEx) as a predictor of response to nebulized levofloxacin compared with nebulized tobramycin OA
Cited by 9
Semantic Scholar
37 Microbiologic changes observed over 6 months in a randomized, open-label comparison of inhaled levofloxacin and inhaled tobramycin in persons with cystic fibrosis and chronic P. aeruginosa (Pa) airway infection OA
Cited by 7
Semantic Scholar
Research Topics
Erythropoietin and Anemia Treatment
(9)
Monoclonal and Polyclonal Antibodies Research
(5)
Dialysis and Renal Disease Management
(4)
Systemic Lupus Erythematosus Research
(4)
Renal Diseases and Glomerulopathies
(4)
Affiliations
Brigham and Women's Hospital
Harvard University
Medical University of Silesia
Royal Derby Hospital
Morriston Hospital
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.